Clinical Trial Update: Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial in HIV infection assessed changes in bone mineral density after switching from tenofovir disoproxil fumarate to abacavir; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)
• Ziagen (Abacavir)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV | Phase 3 | Status: COMPLETED